Wai Yuen Tong Medicine Holdings (HKSE:00897) 3-Year RORE % : -62.33% (As of Sep. 2023)

Wai Yuen Tong Medicine Holdings 3-Year RORE % Chart

Wai Yuen Tong Medicine Holdings Annual Data
	Trend	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
3-Year RORE %		Get a 7-Day Free Trial					-119.21	137.54	-328.83	1,200.00	-70.24

Wai Yuen Tong Medicine Holdings Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
3-Year RORE %	Get a 7-Day Free Trial															-179.12	1,200.00	271.03	-70.24	-62.33

Competitive Comparison of Wai Yuen Tong Medicine Holdings's 3-Year RORE %

For the Drug Manufacturers - Specialty & Generic subindustry, Wai Yuen Tong Medicine Holdings's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wai Yuen Tong Medicine Holdings's 3-Year RORE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wai Yuen Tong Medicine Holdings's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Wai Yuen Tong Medicine Holdings's 3-Year RORE % falls into.

Wai Yuen Tong Medicine Holdings 3-Year RORE % Calculation

Wai Yuen Tong Medicine Holdings's 3-Year RORE % for the quarter that ended in Sep. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2023 and 3-year before.

Wai Yuen Tong Medicine Holdings  (HKSE:00897) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.

Wai Yuen Tong Medicine Holdings 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of Wai Yuen Tong Medicine Holdings's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Wai Yuen Tong Medicine Holdings (HKSE:00897) Business Description